Shuttle Pharmaceuticals Stock Buy Hold or Sell Recommendation
| SHPH Stock | USD 0.60 0.01 1.64% |
Given the investment horizon of 90 days and your complete indifference towards market risk, our recommendation regarding Shuttle Pharmaceuticals is 'Buy'. The recommendation algorithm takes into account all of Shuttle Pharmaceuticals' available fundamental, technical, and predictive indicators you will find on this site.
Check out Shuttle Pharmaceuticals Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more detail on how to invest in Shuttle Stock please use our How to Invest in Shuttle Pharmaceuticals guide. In addition, we conduct extensive research on individual companies such as Shuttle and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Shuttle Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
Shuttle |
Execute Shuttle Pharmaceuticals Buy or Sell Advice
The Shuttle recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Shuttle Pharmaceuticals. Macroaxis does not own or have any residual interests in Shuttle Pharmaceuticals or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Shuttle Pharmaceuticals' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Buy
Market Performance | Very Weak | Details | |
Volatility | Out of control | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Fairly Valued | Details | |
Odds Of Distress | Very High | Details | |
Economic Sensitivity | Almost mirrors the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Not Available | Details | |
Financial Strenth (F Score) | Poor | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Shuttle Pharmaceuticals Trading Alerts and Improvement Suggestions
| Shuttle Pharmaceuticals generated a negative expected return over the last 90 days | |
| Shuttle Pharmaceuticals has high historical volatility and very poor performance | |
| Shuttle Pharmaceuticals has some characteristics of a very speculative penny stock | |
| Shuttle Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| Shuttle Pharmaceuticals currently holds 1.09 M in liabilities with Debt to Equity (D/E) ratio of 0.09, which may suggest the company is not taking enough advantage from borrowing. Shuttle Pharmaceuticals has a current ratio of 0.03, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Shuttle Pharmaceuticals' use of debt, we should always consider it together with its cash and equity. | |
| Net Loss for the year was (6.59 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Shuttle Pharmaceuticals currently holds about 50.44 K in cash with (5.58 M) of positive cash flow from operations. | |
| Shuttle Pharmaceuticals has a poor financial position based on the latest SEC disclosures | |
| Roughly 19.0% of Shuttle Pharmaceuticals outstanding shares are owned by corporate insiders | |
| Latest headline from news.google.com: Why Five9 Shares Are Trading Higher By Around 13 Here Are 20 Stocks Moving Premarket - Benzinga India |
Shuttle Pharmaceuticals Returns Distribution Density
The distribution of Shuttle Pharmaceuticals' historical returns is an attempt to chart the uncertainty of Shuttle Pharmaceuticals' future price movements. The chart of the probability distribution of Shuttle Pharmaceuticals daily returns describes the distribution of returns around its average expected value. We use Shuttle Pharmaceuticals price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Shuttle Pharmaceuticals returns is essential to provide solid investment advice for Shuttle Pharmaceuticals.
| Mean Return | -0.54 | Value At Risk | -6.25 | Potential Upside | 11.36 | Standard Deviation | 5.06 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Shuttle Pharmaceuticals historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Shuttle Stock Institutional Investors
| Shares | Armistice Capital, Llc | 2024-12-31 | 306.1 K | Ubs Group Ag | 2024-12-31 | 32.8 K | Geode Capital Management, Llc | 2024-12-31 | 10.9 K | Tower Research Capital Llc | 2024-12-31 | 6.9 K | Federation Des Caisses Desjardins Du Quebec | 2024-09-30 | 63.0 | Bank Of America Corp | 2024-12-31 | 23.0 | Hrt Financial Llc | 2024-12-31 | 0.0 |
Shuttle Pharmaceuticals Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Shuttle Pharmaceuticals or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Shuttle Pharmaceuticals' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Shuttle stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.55 | |
β | Beta against Dow Jones | 1.06 | |
σ | Overall volatility | 5.33 | |
Ir | Information ratio | -0.11 |
Shuttle Pharmaceuticals Volatility Alert
Shuttle Pharmaceuticals exhibits very low volatility with skewness of 0.86 and kurtosis of 0.26. Shuttle Pharmaceuticals is a potential penny stock. Although Shuttle Pharmaceuticals may be in fact a good instrument to invest, many penny stocks are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in Shuttle Pharmaceuticals. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Shuttle instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Shuttle Pharmaceuticals Fundamentals Vs Peers
Comparing Shuttle Pharmaceuticals' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Shuttle Pharmaceuticals' direct or indirect competition across all of the common fundamentals between Shuttle Pharmaceuticals and the related equities. This way, we can detect undervalued stocks with similar characteristics as Shuttle Pharmaceuticals or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Shuttle Pharmaceuticals' fundamental indicators could also be used in its relative valuation, which is a method of valuing Shuttle Pharmaceuticals by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Shuttle Pharmaceuticals to competition |
| Fundamentals | Shuttle Pharmaceuticals | Peer Average |
| Return On Equity | -4.28 | -0.31 |
| Return On Asset | -1.12 | -0.14 |
| Current Valuation | 2.91 M | 16.62 B |
| Shares Outstanding | 4.08 M | 571.82 M |
| Shares Owned By Insiders | 19.40 % | 10.09 % |
| Shares Owned By Institutions | 9.42 % | 39.21 % |
| Number Of Shares Shorted | 9.29 K | 4.71 M |
| Price To Book | 4.16 X | 9.51 X |
| EBITDA | (3.99 M) | 3.9 B |
| Net Income | (6.59 M) | 570.98 M |
| Cash And Equivalents | 50.44 K | 2.7 B |
| Total Debt | 1.09 M | 5.32 B |
| Debt To Equity | 0.09 % | 48.70 % |
| Current Ratio | 0.03 X | 2.16 X |
| Book Value Per Share | (0.45) X | 1.93 K |
| Cash Flow From Operations | (5.58 M) | 971.22 M |
| Short Ratio | 0.12 X | 4.00 X |
| Earnings Per Share | (4.25) X | 3.12 X |
| Number Of Employees | 8 | 18.84 K |
| Beta | 0.26 | -0.15 |
| Market Capitalization | 2.46 M | 19.03 B |
| Total Asset | 5.95 M | 29.47 B |
| Retained Earnings | (25.43 M) | 9.33 B |
| Working Capital | 4.55 M | 1.48 B |
| Net Asset | 5.95 M |
Note: Disposition of 8372 shares by Dritschilo Anatoly of Shuttle Pharmaceuticals at 1.605 subject to Rule 16b-3 [view details]
Shuttle Pharmaceuticals Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Shuttle . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Shuttle Pharmaceuticals Buy or Sell Advice
When is the right time to buy or sell Shuttle Pharmaceuticals? Buying financial instruments such as Shuttle Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Shuttle Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Millennials Best Thematic Idea Now
Millennials Best
Companies or funds that provide products or services that appeal to the generation of millennials and that are expected to experience growth in the next 5 years. The millennial generation usually refers to the demographic population that were born between 1980 to 2000. The Millennials Best theme has 50 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Millennials Best Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Shuttle Pharmaceuticals Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more detail on how to invest in Shuttle Stock please use our How to Invest in Shuttle Pharmaceuticals guide.You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Shuttle Pharmaceuticals. If investors know Shuttle will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Shuttle Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Shuttle Pharmaceuticals is measured differently than its book value, which is the value of Shuttle that is recorded on the company's balance sheet. Investors also form their own opinion of Shuttle Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Shuttle Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Shuttle Pharmaceuticals' market value can be influenced by many factors that don't directly affect Shuttle Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Shuttle Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Shuttle Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Shuttle Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.